Crux Biomedical Overview
- Year Founded
-
2004

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$39M
- Investors
-
1
Crux Biomedical General Information
Description
Developer of a preventive device for pulmonary embolisms. The company provide Crux VCF System, that stops the blood clots from reaching the lungs. It is useful for patients at risk of pulmonary embolism who can't tolerate blood thinners, method of preventing clots.
Contact Information
Website
www.cruxbiomedical.comCorporate Office
- 1455 Adams Drive
- Suite 1170
- Menlo Park, CA 94025
- United States
Corporate Office
- 1455 Adams Drive
- Suite 1170
- Menlo Park, CA 94025
- United States
Crux Biomedical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 12-Dec-2012 | $39M | Completed | Generating Revenue | ||
6. Later Stage VC (Series D) | 07-Jun-2011 | Completed | Generating Revenue | |||
5. Later Stage VC (Series C) | 01-Mar-2011 | Completed | Generating Revenue | |||
4. Later Stage VC | 22-Jan-2009 | Completed | Generating Revenue | |||
3. Later Stage VC | 08-Dec-2008 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B) | 02-Oct-2007 | $2.5M | $6.35M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 18-Sep-2006 | $3.85M | $3.85M | Completed | Product Development |
Crux Biomedical Patents
Crux Biomedical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20160066880-A1 | Distal protection systems and methods with pressure and ultrasound features | Active | 15-Mar-2013 | ||
US-20160022292-A1 | Retrieval and centering device and method with pressure and ultrasound features | Inactive | 15-Mar-2013 | ||
US-10213288-B2 | Distal protection filter | Active | 06-Mar-2012 | ||
US-20130238010-A1 | Distal protection filter | Active | 06-Mar-2012 | ||
US-10433945-B2 | Retrieval snare device and method | Active | 13-Jan-2012 | A61F2/01 |
Crux Biomedical Former Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alloy Ventures | Venture Capital | Minority | ||
Emergent Medical Partners | Venture Capital | Minority | ||
Hercules Capital | Lender/Debt Provider | Minority | ||
Three Arch Partners | Venture Capital | Minority |
Crux Biomedical FAQs
-
When was Crux Biomedical founded?
Crux Biomedical was founded in 2004.
-
Where is Crux Biomedical headquartered?
Crux Biomedical is headquartered in Menlo Park, CA.
-
What industry is Crux Biomedical in?
Crux Biomedical’s primary industry is Surgical Devices.
-
Is Crux Biomedical a private or public company?
Crux Biomedical is a Private company.
-
What is the current valuation of Crux Biomedical?
The current valuation of Crux Biomedical is
. -
What is Crux Biomedical’s current revenue?
The current revenue for Crux Biomedical is
. -
How much funding has Crux Biomedical raised over time?
Crux Biomedical has raised $30.6M.
-
Who are Crux Biomedical’s investors?
Alloy Ventures, Emergent Medical Partners, Hercules Capital, and Three Arch Partners have invested in Crux Biomedical.
-
When was Crux Biomedical acquired?
Crux Biomedical was acquired on 12-Dec-2012.
-
Who acquired Crux Biomedical?
Crux Biomedical was acquired by Volcano.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »